A guinea pig model of low-dose Mycobacterium bovis aerogenic infection

被引:27
作者
Chambers, MA
Williams, A
Gavier-Widén, D
Whelan, A
Hughes, C
Hall, G
Lever, MS
Marsh, PD
Hewinson, RG
机构
[1] Publ Hlth Lab Serv, Ctr Appl Microbiol & Res, Salisbury SP4 0JG, Wilts, England
[2] Vet Labs Agcy Weybridge, Dept Pathol, Addlestone KT15 3NB, Surrey, England
[3] Vet Labs Agcy Weybridge, Qual Control Unit, Addlestone KT15 3NB, Surrey, England
[4] Vet Labs Agcy Weybridge, Dept Bacterial Dis, TB Res Grp, Addlestone KT15 3NB, Surrey, England
关键词
airborne infection; guinea pig model; Mycobacterium bovis;
D O I
10.1016/S0378-1135(00)00378-3
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In order to develop a model of Mycobacterium bovis infection with pathogenetical relevance, a modified version of the Henderson apparatus was used to deliver infectious aerosols directly to the snouts of guinea pigs. Aerosols generated from 10(6), 10(7), 10(8) CFU/ml M. bovis suspensions established disease in every animal, with estimated retained doses of 10, 100, 1000 CFU, respectively. For comparison, other guinea pigs were inoculated with 100 CFU M. bovis intramuscularly (i.m.). Pathology and bacterial colonisation of lungs and spleen varied according to the dose and route of inoculation. Animals inoculated i.m. gave a significant cutaneous tuberculin hypersensitivity reaction earlier after testing than those infected aerogenically. A serological response to M. bovis antigens was detected in all infected animals. Intensity of antigen recognition was dose-dependent and although the range of antigens recognised varied between animals, a 25 kDa antigen present in the cell fraction was serodominant. Thus, a reproducible guinea pig model has been defined that may be suitable for virulence, vaccination, and immunological studies. Crown Copyright (C) 2001 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:213 / 226
页数:14
相关论文
共 41 条
[1]  
[Anonymous], 1958, Tuberculosis in Animals and Man. A Study in Comparative Pathology
[2]   Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis [J].
Baldwin, SL ;
D'Souza, C ;
Roberts, AD ;
Kelly, BP ;
Frank, AA ;
Lui, MA ;
Ulmer, JB ;
Huygen, K ;
McMurray, DM ;
Orme, IM .
INFECTION AND IMMUNITY, 1998, 66 (06) :2951-2959
[3]  
BASKERVILLE A, 1981, LANCET, V2, P1389
[4]  
CHAPARAS SD, 1975, AM REV RESPIR DIS, V112, P43
[5]   MYCOBACTERIUM-BOVIS IN THE EUROPEAN BADGER (MELES-MELES) - EPIDEMIOLOGIC FINDINGS IN TUBERCULOUS BADGERS FROM A NATURALLY INFECTED-POPULATION [J].
CLIFTONHADLEY, RS ;
WILESMITH, JW ;
STUART, FA .
EPIDEMIOLOGY AND INFECTION, 1993, 111 (01) :9-19
[6]   EFFECTS OF DIET AND GENETICS ON MYCOBACTERIUM-BOVIS BCG VACCINE EFFICACY IN INBRED GUINEA-PIGS [J].
COHEN, MK ;
BARTOW, RA ;
MINTZER, CL ;
MCMURRAY, DN .
INFECTION AND IMMUNITY, 1987, 55 (02) :314-319
[7]   Zoonotic tuberculosis due to Mycobacterium bovis in developing countries [J].
Cosivi, O ;
Grange, JM ;
Daborn, CJ ;
Raviglione, MC ;
Fujikura, T ;
Cousins, D ;
Robinson, RA ;
Huchzermeyer, HFAK ;
de Kantor, I ;
Meslin, FX .
EMERGING INFECTIOUS DISEASES, 1998, 4 (01) :59-70
[8]  
Daborn C. J., 1996, V25, p27S
[9]   MYCOBACTERIUM-BOVIS INFECTIONS IN SAN-DIEGO - A CLINICOEPIDEMIOLOGIC STUDY OF 73 PATIENTS AND A HISTORICAL REVIEW OF A FORGOTTEN PATHOGEN [J].
DANKNER, WM ;
WAECKER, NJ ;
ESSEY, MA ;
MOSER, K ;
THOMPSON, M ;
DAVIS, CE .
MEDICINE, 1993, 72 (01) :11-37
[10]  
Dorset M., 1902, AM MED, V3, P555